BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35356684)

  • 1.
    Alsing S; Doktor TK; Askou AL; Jensen EG; Ahmadov U; Kristensen LS; Andresen BS; Aagaard L; Corydon TJ
    Mol Ther Nucleic Acids; 2022 Jun; 28():58-76. PubMed ID: 35356684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds.
    Kaadt E; Alsing S; Cecchi CR; Damgaard CK; Corydon TJ; Aagaard L
    Mol Ther Nucleic Acids; 2019 Mar; 14():318-328. PubMed ID: 30654192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards Antiviral shRNAs Based on the AgoshRNA Design.
    Liu YP; Karg M; Herrera-Carrillo E; Berkhout B
    PLoS One; 2015; 10(6):e0128618. PubMed ID: 26087209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of HIV-1 by AgoshRNA molecules.
    Herrera-Carrillo E; Harwig A; Berkhout B
    Gene Ther; 2017 Aug; 24(8):453-461. PubMed ID: 28553929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.
    Guda S; Brendel C; Renella R; Du P; Bauer DE; Canver MC; Grenier JK; Grimson AW; Kamran SC; Thornton J; de Boer H; Root DE; Milsom MD; Orkin SH; Gregory RI; Williams DA
    Mol Ther; 2015 Sep; 23(9):1465-74. PubMed ID: 26080908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.
    Liu YP; Karg M; Harwig A; Herrera-Carrillo E; Jongejan A; van Kampen A; Berkhout B
    RNA Biol; 2015; 12(1):92-100. PubMed ID: 25826416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
    Liu XY; Tang QS; Chen HC; Jiang XL; Fang H
    Int J Biol Sci; 2013; 9(6):564-77. PubMed ID: 23847439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.
    Herrera-Carrillo E; Harwig A; Berkhout B
    RNA Biol; 2015; 12(4):447-56. PubMed ID: 25747107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.
    Herrera-Carrillo E; Gao Z; Berkhout B
    Mol Ther Nucleic Acids; 2019 Jun; 16():452-462. PubMed ID: 31048184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells.
    Holmgaard A; Askou AL; Benckendorff JNE; Thomsen EA; Cai Y; Bek T; Mikkelsen JG; Corydon TJ
    Mol Ther Nucleic Acids; 2017 Dec; 9():89-99. PubMed ID: 29246327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
    Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
    BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
    Jiang Y; Wang H; Culp D; Yang Z; Fotheringham L; Flannery J; Hammond S; Kafri T; Hartnett ME
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):824-31. PubMed ID: 24425851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium.
    Paskowitz DM; Greenberg KP; Yasumura D; Grimm D; Yang H; Duncan JL; Kay MA; Lavail MM; Flannery JG; Vollrath D
    Hum Gene Ther; 2007 Oct; 18(10):871-80. PubMed ID: 17892416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting AgoshRNA activity by optimized 5'-terminal nucleotide selection.
    Gao Z; Berkhout B; Herrera-Carrillo E
    RNA Biol; 2019 Jul; 16(7):890-898. PubMed ID: 30991896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous MicroRNA Competition as a Mechanism of shRNA-Induced Cardiotoxicity.
    Course MM; Gudsnuk K; Desai N; Chamberlain JR; Valdmanis PN
    Mol Ther Nucleic Acids; 2020 Mar; 19():572-580. PubMed ID: 31927330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of AgoshRNA maturation and loading into Ago2.
    Harwig A; Kruize Z; Yang Z; Restle T; Berkhout B
    PLoS One; 2017; 12(8):e0183269. PubMed ID: 28809941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton's Jelly Stem Cells.
    Estiri H; Fallah A; Soleimani M; Aliaghaei A; Karimzadeh F; Babaei Abraki S; Ghahremani MH
    Cell J; 2018 Apr; 20(1):1-9. PubMed ID: 29308612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.